The present Feasibility Randomized Controlled Trial (FRCT) aims to assess the acceptability and effectiveness of REDCHiP intervention, targeting parents of young children with T1D, followed in two major Portuguese hospitals. The objective of this trial is to evaluate (1) acceptability and feasibility by evaluating recruitment and retention rates, attendance throughout the sessions, and responses to parent satisfaction; (2) effectiveness by analyzing changes in parents' FH, diabetes distress (DD), emotional regulation (ER), resilient coping skills (RC), and anxiety and depression as well as changes in child glycemic outcomes (HbA1c, GMI, TBR, TIR, TAR) at three time points among participants allocated on intervention versus Treatment As Usual (TAU) group. Finally, (3) the investigators aim to qualitatively evaluate participant´s experiences and feedback regarding the REDHIP intervention through interviews.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Parents Fear of Hypoglycemia
Timeframe: From baseline to post-intervention (14-15 week)
Parents Diabetes Distress
Timeframe: From baseline to post-intervention (14-15 week)
Children Glycemic Outcomes
Timeframe: From baseline to post-intervention (14-15 week)
Children Glycemic Outcomes
Timeframe: From baseline to post-intervention (14-15 week)
Children Glycemic Outcomes
Timeframe: From baseline to post-intervention (14-15 week)
Children Glycemic Outcomes
Timeframe: From baseline to post-intervention (14-15 week)
Children Glycemic Outcomes
Timeframe: From baseline to post-intervention (14-15 week)